Market News AIOpen the app

Perspective Therapeutics, Inc. says the FDA gave Fast Track status to its drug PSV359 for treating some tumors.

TrialRead the original at SEC EDGAR
Good for CATX

Perspective Therapeutics received FDA Fast Track status for PSV359 in adults with a rare tumor. This supports development, but does not mean the drug is approved.

CATX · Perspective Therapeutics, Inc.

AI read · Good for CATX

The AI's read

This is a favorable step for PSV359's development for adults with this tumor type. Fast Track status is not FDA approval, and the filing reports no treatment results. The news supports Perspective Therapeutics, but does not show whether the drug works or when it could reach patients.

Get alerts for CATX

Follow Perspective Therapeutics, Inc. (CATX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CATX
Free on the App Store and Google Play, or on the web.